Vaxart (VXRT) Tops Q2 EPS by 6c

Vaxart (NASDAQ: VXRT) reported Q2 EPS of ($0.09), $0.06 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.4 million versus the consensus estimate of $66.67 thousand.

For earnings history and earnings-related data on Vaxart (VXRT) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Shell Acquires interest in Gulf of America prospect
• White House: barrels from Venezuela deal could hit reserves in U.S. In November